Pancreatic carcinoma-specific immunotherapy using synthesised alpha-galactosyl epitope-activated immune responders: findings from a pilot study

Dendritic Cells as Killers: Mechanistic Aspects and Potential Roles

(2014) C. Chauvin et al.   JOURNAL OF IMMUNOLOGY

Comparative study on anti-tumor immune response of autologous cytokine-induced killer (CIK) cells, dendritic cells-CIK (DC-CIK), and semi-allogeneic DC-CIK

(2012) Qi-Jing Wang et al.   Chinese Journal of Cancer

Dendritic cell-based vaccination of patients with advanced pancreatic carcinoma: results of a pilot study

(2011) Christian Bauer et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Pancreatic Cancer Alters Human CD4+ T Lymphocyte Function

(2011) Paola Fogar et al.   PANCREAS

Prognostic factors for resectable pancreatic adenocarcinoma

(2011) C. Neuzillet et al.   Journal of Visceral Surgery

Increased Immunogenicity of Tumor-Associated Antigen, Mucin 1, Engineered to Express  -Gal Epitopes: A Novel Approach to Immunotherapy in Pancreatic Cancer

(2010) T. Deguchi et al.   CANCER RESEARCH

Dendritic Cell-Based Vaccines for Pancreatic Cancer and Melanoma

(2009) James J. Mulé   Annals of the New York Academy of Sciences

The Antitumor and Immunoadjuvant Effects of IFN-  in Combination with Recombinant Poxvirus Vaccines

(2009) K. W. Hance et al.   CLINICAL CANCER RESEARCH

Impact of surgery and chemotherapy on cellular immunity in pancreatic carcinoma patients in view of an integration of standard cancer treatment with immunotherapy

(2009) Bellone   INTERNATIONAL JOURNAL OF ONCOLOGY

Morphological Analysis of Pancreatic Adenocarcinoma on Multidetector Row Computed Tomography

(2009) Pedram Rezai et al.   PANCREAS

Gemcitabine and oxaliplatin combination as first-line treatment for advanced pancreatic cancer: a multicenter phase II study

(2008) Kyung Hee Lee et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Recombinant Human C1-Inhibitor Inhibits Cytotoxicity Induced by Allo- and Xenoantibodies

(2008) N. Poirier et al.   TRANSPLANTATION PROCEEDINGS